Evidence map›Paper›PMID 39329815›Full record

ArticleBiosensors2024

All-Dielectric Metasurface-Based Terahertz Molecular Fingerprint Sensor for Trace Cinnamoylglycine Detection.

Qiyuan Xu, Mingjun Sun, Weijin Wang, Yanpeng Shi

Abstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qiyuan XuSchool of Integrated Circuits, Shandong University, Jinan 250100, China.
Mingjun SunSchool of Integrated Circuits, Shandong University, Jinan 250100, China.ORCID 0009-0005-0972-4464
Weijin WangSchool of Integrated Circuits, Shandong University, Jinan 250100, China.ORCID 0009-0006-1420-281X
Yanpeng ShiSchool of Integrated Circuits, Shandong University, Jinan 250100, China.ORCID 0000-0003-1970-5783

Funding

Fundamental Research Fund of Shandong University 2018TB002Jinan-SDU Co-development JNSX2023007National Natural Science Foundation of China 61805127Natural Science Fundation of Shandong Province ZR2019BF014
6 · The paper itself

Abstract

Terahertz (THZ) spectroscopy has emerged as a superior label-free sensing technology in the detection, identification, and quantification of biomolecules in various biological samples. However, the limitations in identification and discrimination sensitivity of current methods impede the wider adoption of this technology. In this article, a meticulously designed metasurface is proposed for molecular fingerprint enhancement, consisting of a periodic array of lithium tantalate triangular prism tetramers arranged in a square quartz lattice. The physical mechanism is explained by the finite-difference time-domain (FDTD) method. The metasurface achieves a high quality factor (Q-factor) of 231 and demonstrates excellent THz sensing capabilities with a figure of merit (FoM) of 609. By varying the incident angle of the THz wave, the molecular fingerprint signal is strengthened, enabling the highly sensitive detection of trace amounts of analyte. Consequently, cinnamoylglycine can be detected with a sensitivity limit as low as 1.23 μg·cm-2. This study offers critical insights into the advanced application of THz waves in biomedicine, particularly for the detection of urinary biomarkers in various diseases, including gestational diabetes mellitus (GDM).

Indexed as

Biosensing TechniquesGlycineTerahertz SpectroscopyHumansLimit of DetectionGlycineall-dielectric metasurfacecinnamoylglycinegestational diabetes mellitusmolecular fingerprint sensorterahertz

Identifiers

PMID39329815
PMCPMC11430580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.